249 related articles for article (PubMed ID: 20832981)
1. Methylnaltrexone in the treatment of opioid-induced constipation in cancer patients receiving palliative care: willingness-to-pay and cost-benefit analysis.
Iskedjian M; Iyer S; Librach SL; Wang M; Farah B; Berbari J
J Pain Symptom Manage; 2011 Jan; 41(1):104-15. PubMed ID: 20832981
[TBL] [Abstract][Full Text] [Related]
2. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
Earnshaw SR; Klok RM; Iyer S; McDade C
Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
[TBL] [Abstract][Full Text] [Related]
3. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
4. Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.
Kyle G
Int J Palliat Nurs; 2009 Nov; 15(11):533-40. PubMed ID: 20081727
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.
Michna E; Blonsky ER; Schulman S; Tzanis E; Manley A; Zhang H; Iyer S; Randazzo B
J Pain; 2011 May; 12(5):554-62. PubMed ID: 21429809
[TBL] [Abstract][Full Text] [Related]
7. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW
BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276
[TBL] [Abstract][Full Text] [Related]
8. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
Candy B; Jones L; Goodman ML; Drake R; Tookman A
Cochrane Database Syst Rev; 2011 Jan; (1):CD003448. PubMed ID: 21249653
[TBL] [Abstract][Full Text] [Related]
9. Methylnaltrexone for Opioid-Induced Constipation in Children and Adolescents and Young Adults with Progressive Incurable Cancer at the End of Life.
Flerlage JE; Baker JN
J Palliat Med; 2015 Jul; 18(7):631-3. PubMed ID: 25927665
[TBL] [Abstract][Full Text] [Related]
10. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
Gatti A; Sabato AF
Clin Drug Investig; 2012 May; 32(5):293-301. PubMed ID: 22413747
[TBL] [Abstract][Full Text] [Related]
11. Methylnaltrexone: treatment for opioid-induced constipation.
Licup N; Baumrucker SJ
Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
[TBL] [Abstract][Full Text] [Related]
12. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
[TBL] [Abstract][Full Text] [Related]
13. Methylnaltrexone bromide for the treatment of opioid-induced constipation.
Mozaffari S; Nikfar S; Abdollahi M
Expert Opin Pharmacother; 2018 Jul; 19(10):1127-1135. PubMed ID: 29979903
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
[TBL] [Abstract][Full Text] [Related]
15. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
16. Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation.
Clark K; Rowett D; Robinson M; Currow DC
BMJ Support Palliat Care; 2013 Mar; 3(1):98-102. PubMed ID: 24644334
[TBL] [Abstract][Full Text] [Related]
17. Methylnaltrexone for opioid-induced constipation in advanced illness.
Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
[TBL] [Abstract][Full Text] [Related]
18. Treating constipation in palliative care: the impact of other factors aside from opioids.
Clark K; Byfieldt N; Dawe M; Currow DC
Am J Hosp Palliat Care; 2012 Mar; 29(2):122-5. PubMed ID: 21606123
[TBL] [Abstract][Full Text] [Related]
19. Paediatric palliative care: intravenous methylnaltrexone relieves constipation.
Yeomanson D; Chohan O; Mayer A
BMJ Support Palliat Care; 2013 Mar; 3(1):103-5. PubMed ID: 24644335
[TBL] [Abstract][Full Text] [Related]
20. Response Rates to Methylnaltrexone in Hospitalized Cancer Patients.
Harris D; Kalir D; Chevalier C; Dobbie K; Fielding F; Lagman R; Makhoul A; McInnes S; Najafi S; Neale K; Rybicki L; Robbins-Ong M; Neuendorf K
Am J Hosp Palliat Care; 2023 Oct; 40(10):1093-1097. PubMed ID: 36565253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
